Production (Stage)
XBiotech Inc.
XBIT
$2.84
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.93M | 927.00K | 777.00K | 1.98M | 1.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.55M | 8.75M | 7.90M | 14.97M | 10.85M |
| Operating Income | -13.55M | -8.75M | -7.90M | -14.97M | -10.85M |
| Income Before Tax | -10.86M | -10.55M | -5.01M | -13.03M | -9.98M |
| Income Tax Expenses | 29.00K | -41.00K | 9.00K | -25.00K | 25.00K |
| Earnings from Continuing Operations | -10.88M | -10.51M | -5.02M | -13.01M | -10.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.88M | -10.51M | -5.02M | -13.01M | -10.00M |
| EBIT | -13.55M | -8.75M | -7.90M | -14.97M | -10.85M |
| EBITDA | -13.11M | -8.31M | -7.47M | -14.53M | -10.42M |
| EPS Basic | -0.36 | -0.34 | -0.16 | -0.43 | -0.33 |
| Normalized Basic EPS | -0.22 | -0.22 | -0.10 | -0.27 | -0.20 |
| EPS Diluted | -0.36 | -0.34 | -0.16 | -0.43 | -0.33 |
| Normalized Diluted EPS | -0.22 | -0.22 | -0.10 | -0.27 | -0.20 |
| Average Basic Shares Outstanding | 30.49M | 30.47M | 30.47M | 30.46M | 30.44M |
| Average Diluted Shares Outstanding | 30.49M | 30.47M | 30.47M | 30.46M | 30.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |